Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0112-2017

Drug recall · October 26, 2016

Trokendi XR recall

Why: Superpotent Drug: Failure of assay specifications in the capsule.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15

Lots / codes

Lot # 426636, Exp 4/22/18

Quantity
17,128 (30-count blister packs)
Company
Supernus Pharmaceuticals, Inc., Rockville, MD
Distribution
Nationwide
Initiated
July 12, 2016 · Voluntary: Firm initiated
Classified
October 20, 2016
Reported
October 26, 2016
Ended
February 26, 2019
How notified
E-Mail

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Trokendi

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.